Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

NICE approves Cimzia but blocks Ilumetri in treatment of psoriasis

December 4, 2018 Manufacturing and Production, Sales and Marketing Almirall, Cimzia, Ilumetri, NICE, UCB, UK, pharma, psoriasis

UK drug watchdog NICE has announced two new recommendations relating to medicines for the treatment of psoriasis, approving UCB Pharma’s …
News

Pfizer’s biosimilar proves non-inferior to rituximab in lymphoma at ASH 2018

December 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASH 2018, Pfizer, haemophilia

Joining the chorus of data presentations at the American Society of Hematology (ASH) Annual Meeting 2018, Pfizer has announced new …
News
shutterstock_243110086

Hemlibra shows “clinically meaningful” bleed control in paediatric haemophilia A patients

December 4, 2018 Manufacturing and Production, Research and Development ASH 2018, Hemlibra, Roche, haemophilia, pharma

In another reveal at the American Society of Hematology (ASH) Annual Meeting 2018, Roche unveiled new Phase 3 findings for …
News
institute_of_cancer_research

Cancer drug access for NHS patients is slowing, ICR reports

December 4, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Cancer, ICR, Institute of Cancer Research, NHS, NICE, UK, pharma

A new report from the Institute of Cancer Research (ICR) has indicated that NHS patients in the UK are suffering …
News
roche

Roche chooses Veeva Vault PromoMats for digital asset management and content

December 4, 2018 Manufacturing and Production, Medical Communications Roche, pharma, veeva

Today, at the 2018 Veeva Commercial & Medical Summit Europe, Roche (SWX:ROG) announced that it would be adopting Veeva Systems …
News

Insider Interview: The diabetes/mental health connection

December 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Type 1 diabetes, World Diabetes Day, diabetes, feature, mental health, pharma

Michael Connellan, Head of External Affairs at the type 1 diabetes charity JDRF, discusses the results of a recent survey …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, Immuno Biotech, NHS, Roche, autism, biosimilars, pharma, top ten

We’ve come to the end of November, and with only one month of the year left to go, the industry …
News
shutterstock_87495637

Pegfilgrastim greenlight marks eighth biosimilar approval in Europe for Sandoz

November 27, 2018 Manufacturing and Production, Sales and Marketing Amgen, Neulasta, Sanofi, Ziextenzo, biosimilars, pegfilgrastim, pharma

The European Commission has chosen to grant marketing authorisation to Ziextenzo, Sandoz’s biosimilar version of pegfilgrastim, better known as Amgen’s …
News
stocks1

Phase 3 failure of asthma therapy sends Vectura’s ailing shares falling

November 27, 2018 Manufacturing and Production, Research and Development asthma, pharma, trial failure, vectura

Vectura has announced it is terminating development of its severe asthma therapy VR475, an inhaled formulation of the corticosteroid budesonide, …
News
nhs_sign

NHS to save £300 million by switching to Humira biosimilars

November 27, 2018 Manufacturing and Production, Sales and Marketing AbbVie, Humira, Mylan, NHS, Sandoz, adalimumab, biosimilars, pharrma

NHS England has announced that the health service is set to save £300 million by switching to biosimilar versions of …
News
bmssyracuseny

BMS’ Opdivo+Yervoy combo fails in small cell lung cancer

November 27, 2018 Manufacturing and Production, Research and Development Bristol-Myers Squibb, Cancer, Yervoy, lung cancer, opdivo, pharma

Bristol-Myers Squibb has revealed that its combo comprising Opdivo (nivolumab) and Yervoy (ipilimumab) failed to meet its primary endpoint as …
News
fda2outsideweb

FDA approves first oral TRK inhibitor with Loxo Oncology’s Vitrakvi

November 27, 2018 Manufacturing and Production, Sales and Marketing Cancer, FDA, Loxo Oncology, Vitrakvi, oncology, pharma

The FDA has announced the approval of the United States’ first-ever oral tyrosine kinase (TRK) inhibitor, Loxo Oncology’s Vitrakvi (larotrectinib), …
News
sunpharma

Sun Pharma’s New Jersey manufacturing overhaul puts 96 jobs at risk

November 26, 2018 Manufacturing and Production, Sales and Marketing Sun Pharma, manufacturing, pharma

Indian pharma firm Sun Pharma has announced it is to combine its New Jersey manufacturing operations in a bid to …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kymriah, Mundipharma, UK, US, brexit, pharma, politics, top 10

The appointment of GSK veteran Arnaud Breabout to the position of Senior Vice President and CFO of Mundipharma took the …
News

Uninsured patients elibible for no-cost replacement of medicines lost in California wildfires

November 22, 2018 Manufacturing and Production, Sales and Marketing USA, california, insurance, prescription, wildfires

Uninsured citizens in California’s Butte, Los Angeles and Ventura counties will be eligible for a no-cost replacement of medicines lost …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026